Dear Researcher,
Drug repurposing is an essential and universal strategy in the development of drugs during this current COVID-19 outbreak. Researchers across the globe are working on the development of candidate vaccines and therapeutics for an effective antiviral molecule. In this newsletter, we are showcasing some of our featured products which are helpful in the R&D of antiviral therapies and can be an essential tool to aid the researchers.

We hope that you find this newsletter to be a valuable source of information.

Chloroquine Metabolite
	Desethyl Chloroquine Catalog No: D288735 A major product of the stereoselective human metabolism of Chloroquine Learn more
Remdesivir Metabolite
	Remdesivir Carboxylic Acid Catalog No: R530520 Major metabolite of Remdesivir (CAS#1809249-37-3)  Remdesivir is currently under clinical trials for mild/ moderate respiratory infection caused by COVID19 Learn more
Fingolimod Impurity
	Fingolimod Palmitate Amide Catalog No: F342050 An impurity of Fingolimod (F805000, HCl salt); a novel immune modulator  Currently under clinical trials for infection caused by COVID19 Learn more
Pirfenidone Metabolite
	5-Carboxy-N-phenyl-2-1H-pyridone Catalog No: C179020 A metabolite of Pirfenidone, which is currently under clinical trials for severe pneumonia caused by COVID19 Learn more
Cobicistat Isomer
	5S-Cobicistat Catalog No: C633140 5S-Cobicistat is an isomer of Cobicistat (C633150), HIV protease inhibitor that has been coadministered with low-dose ritonavir as a pharmacoenhancer. Learn more